|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,090.00 KRW | -0.89% |
|
-2.55% | -13.70% |
| 02-09 | JW Lifescience Corporation announces Annual dividend, payable on April 24, 2026 | CI |
| 11-05 | JW Life Science Q3 operating profit 6.6 billion won, down 30% from year earlier | RE |
| Market Cap | 172B 118M 103M 96.05M 88.14M 166M 11.32B 168M 1.14B 446M 5.57B 441M 432M 19.25B | P/E 2024 |
3.83x | P/E 2025 | 6.96x |
|---|---|---|---|---|---|
| Enterprise Value | 212B 145M 127M 118M 109M 204M 13.97B 207M 1.41B 550M 6.87B 544M 533M 23.74B | EV / Sales 2024 |
1.03x | EV / Sales 2025 | 0.93x |
| Free-Float |
54.08% | Yield 2024 |
4.6% | Yield 2025 | - |
| 1 day | -0.89% | ||
| 1 week | -2.55% | ||
| Current month | -2.63% | ||
| 1 month | -0.18% | ||
| 3 months | -14.43% | ||
| 6 months | -14.10% | ||
| Current year | -13.70% |
| 1 week | 10,850 |  | 11,380 |
| 1 month | 10,850 | | 11,850 |
| Current year | 10,600 | | 14,000 |
| 1 year | 10,600 | | 15,580 |
| 3 years | 10,000 | | 15,580 |
| 5 years | 10,000 | | 19,250 |
| 10 years | 10,000 | | 34,450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung-Yeol Noh
CEO | Chief Executive Officer | 59 | 2024-02-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Eun-Kyung Ham
BRD | Director/Board Member | 63 | 2017-02-16 |
Jung-Yeol Noh
BRD | Director/Board Member | 59 | - |
Byeong-Suk Lee
BRD | Director/Board Member | 70 | 2022-03-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.89% | -2.55% | -11.63% | -19.17% | 118M | |
| +0.86% | +1.43% | +47.17% | +161.40% | 1,067B | |
| +1.59% | +4.09% | +56.51% | +52.79% | 635B | |
| +0.95% | +1.91% | +36.30% | +83.13% | 458B | |
| +1.60% | +6.25% | +37.00% | +30.00% | 347B | |
| -0.60% | +1.52% | +36.67% | +39.80% | 295B | |
| -0.14% | +0.60% | +17.29% | +18.19% | 262B | |
| +0.09% | -2.82% | -29.09% | -41.29% | 216B | |
| +1.22% | +2.66% | +22.66% | +59.81% | 203B | |
| -1.18% | -3.70% | +11.28% | +67.43% | 161B | |
| Average | +0.35% | +1.20% | +22.42% | +45.21% | 364.36B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +78.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 222B 152M 134M 124M 114M 215M 14.67B 218M 1.48B 577M 7.21B 572M 560M 24.94B | 258B 177M 155M 144M 132M 249M 17B 252M 1.71B 669M 8.36B 663M 648M 28.9B |
| Net income | 43.99B 30.12M 26.46M 24.6M 22.58M 42.42M 2.9B 43.07M 292M 114M 1.43B 113M 111M 4.93B | 28.61B 19.59M 17.2M 16M 14.68M 27.59M 1.89B 28.01M 190M 74.23M 927M 73.53M 71.95M 3.21B |
| Net Debt | 59.62B 40.82M 35.85M 33.34M 30.6M 57.49M 3.93B 58.38M 396M 155M 1.93B 153M 150M 6.68B | 40.08B 27.45M 24.11M 22.42M 20.57M 38.65M 2.64B 39.25M 266M 104M 1.3B 103M 101M 4.49B |
Employees
297
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | ₩11,090.00 | -0.89% | 23,302 |
| 26-07-23 | ₩11,190.00 | +3.04% | 16,827 |
| 26-07-22 | ₩10,860.00 | -1.54% | 33,435 |
| 26-07-21 | ₩11,030.00 | -0.45% | 20,830 |
| 26-07-20 | ₩11,080.00 | -2.64% | 18,278 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A234080 Stock
Select your edition
All financial news and data tailored to specific country editions
